PROTALIX BIOTHERAPEUTICS, INC. (PLX) Revenue 2016–2025
PROTALIX BIOTHERAPEUTICS, INC. (PLX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$52.7MFY2025 · since FY2016: $9.2M → $52.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $52.7M | -1.2% |
| FY2024 | $53.4M | -18.5% |
| FY2023 | $65.5M | +37.5% |
| FY2022 | $47.6M | +24.2% |
| FY2021 | $38.4M | -39.0% |
| FY2020 | $62.9M | +15.0% |
| FY2019 | $54.7M | +59.7% |
| FY2018 | $34.2M | +62.4% |
| FY2017 | $21.1M | +129.1% |
| FY2016 | $9.2M | — |
Source: SEC XBRL filings · For reference only · Not investment advice